Skip to main content
Clinical Trials/IRCT20190415043279N11
IRCT20190415043279N11
Not yet recruiting
Phase 3

Evaluation of the effect of probiotic supplementation on the improvement of proteinuria in patients with immunoglobulin A nephropathy

Sanandaj University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Sanandaj University of Medical Sciences
Enrollment
120
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sanandaj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age over 18 years
  • Early IgA nephropathy diagnosed by biopsy
  • Albuminuria more than 0\.75 grams per day
  • Serum creatinine less than 200 micromoles per liter
  • Creatinine clearance greater than 30 ml per minute

Exclusion Criteria

  • Inflammatory diseases
  • Autoimmune diseases
  • Breastfeeding
  • Secondary IgA nephropathy
  • Allergy to probiotics

Outcomes

Primary Outcomes

Not specified

Similar Trials